Wells Fargo & Company Calyxt, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.13 - $0.44 $0 - $1	3 Added 0.46%	649 $0
Q4 2022 Feb 13, 2023	BUY	$0.13 - $0.2 $1 - $1	9 Added 1.41%	646 $0
Q3 2022 Nov 14, 2022	BUY	$0.17 - $0.3 $3 - $6	20 Added 3.24%	637 $0
Q2 2022 Aug 12, 2022	BUY	$0.24 - $0.91 $8 - $30	34 Added 5.83%	617 $0
Q1 2022 May 16, 2022	SELL	$1.02 - $2.46 $2,448 - $5,904	-2,400 Reduced 80.46%	583 $1,000
Q4 2021 Feb 14, 2022	BUY	$2.06 - $4.05 $6 - $12	3 Added 0.1%	2,983 $6,000
Q3 2021 Nov 15, 2021	SELL	$3.18 - $5.08 $34 - $55	-11 Reduced 0.37%	2,980 $10,000
Q2 2021 Aug 16, 2021	SELL	$3.83 - $6.31 $325,921 - $536,962	-85,097 Reduced 96.6%	2,991 $12,000
Q1 2021 May 13, 2021	BUY	$4.25 - $12.01 $156,629 - $442,616	36,854 Added 71.93%	88,088 $530,000
Q4 2020 Feb 09, 2021	BUY	$3.21 - $5.68 $2,975 - $5,265	927 Added 1.84%	51,234 $216,000
Q3 2020 Nov 05, 2020	SELL	$4.37 - $7.66 $7,380 - $12,937	-1,689 Reduced 3.25%	50,307 $276,000
Q2 2020 Aug 13, 2020	BUY	$2.9 - $6.36 $17,582 - $38,560	6,063 Added 13.2%	51,996 $256,000
Q1 2020 May 14, 2020	BUY	$2.48 - $7.85 $113,913 - $360,574	45,933 New	45,933 $153,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.